Zhuchen Yan

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 10 篇 · 总被引 80 次 · h-index 5

代表论文

• Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study (2023 · BMC Cancer · 被引 28)
• Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis (2024 · Gastric Cancer · 被引 14)
• Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: A real- world study (2022 · Research Square · 被引 13)
• Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities (2024 · Biological Procedures Online · 被引 11)
• Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF‑κB and AP‑1 (2017 · Oncology Letters · 被引 10)
• Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting (2024 · BMC Cancer · 被引 3)